Jeffrey Hubbell | |
---|---|
Born | |
Spouse | Juliet Boege (m. 1983) |
Academic background | |
Education |
|
Thesis | Visualization and Analysis of Mural Thrombogenesis (Platelet Adhesion, Collagen, Polyurethane, Digital Image Processing) (1986) |
Academic work | |
Institutions | |
Notable students | David Scott Wilson |
Jeffrey Alan Hubbell is an American molecular engineer. During his early career,Hubbell founded three companies based on his academic research and was the holder of 88 U.S. patents.
Hubbell was born to father Ron Hubbell in Overland Park,Kansas. [1] He received his bachelor's degree from Kansas State University and his PhD from Rice University in chemical engineering. [2]
Upon completing his PhD,Hubbell joined the faculty at Switzerland's École Polytechnique Fédérale de Lausanne where he served as the founding director of the Institute of Bioengineering. [3] In 1995,Hubbell was elected a fellow of the American Institute for Medical and Biological Engineering for his "fundamental and clinically-applied contributions to biomaterials." [4] During his early career,he founded three companies based on his academic research and was the holder of 88 U.S. patents. Hubbell remained in Switzerland until 2014 when he accepted a position at the University of Chicago faculty of engineering as their Barry L. MacLean Professor for Molecular Engineering Innovation and Enterprise. [3] He was also elected a fellow of the National Academy of Inventors. [5]
Upon joining the University of Chicago,Hubbell collaborated with Cathryn Nagler to establish the ClostraBio,a company to develop drugs. [6] By 2017,Hubbel was the recipient of the Society for Biomaterials’Founders Award for his "long-term,landmark contributions to the discipline of biomaterials." He was specifically recognized for designing materials to assemble and function so they could stimulate the immune system to fight infection or malignancy and coining the term "immuno-modulatory materials." [7] In the same year,Hubbel was awarded the Acta Biomaterialia Gold Medal [8] and appointed the inaugural Bell Professor in Tissue Engineering at the University of Chicago. [9]
In 2018,Hubbell was also elected a Member of the National Academy of Medicine for his work "pioneering the development of cell responsive (bioactive) materials and inventing biomaterials that are now widely utilized in regenerative medicine." [10] Following this,he helped develop a new system for delivering a malaria vaccine. [11]
During the COVID-19 pandemic,Hubbell and Melody Swartz co-launched the Chicago Immunoengineering Innovation Center to develop new technologies to treat diseases,including cancer,autoimmune disorders,and COVID-19. Throughout the pandemic,the researchers at the center began developing computational and experimental approaches to new vaccines and vaccine delivery methods. [12] In April 2020,Hubbell,Swartz,and Jun Ishihara co-published their research on an immunotherapy delivery system that finds tumors by seeking out and binding to the tumors’collagen. [13] Following this development,he helped design a new therapy to assist those with multiple sclerosis by fusing a cytokine to a blood protein. [14] Later,in 2021,Hubbell was one of eight University of Chicago faculty members elected to the American Academy of Arts and Sciences. [15]
Hubbell married speech pathologist Juliet Boege in 1983. [1]
Steven A. Rosenberg is an American cancer researcher and surgeon,chief of Surgery at the National Cancer Institute in Bethesda,Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and the George Washington University School of Medicine and Health Sciences. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies and the development of gene therapy. He is the first researcher to successfully insert foreign genes into humans.
Cato T. Laurencin FREng SLMH is an American engineer,physician,scientist,innovator and a University Professor of the University of Connecticut.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering,drug delivery,bionanotechnology,pharmaceutical sciences,chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale,macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering,an Associate Professor of Surgery,and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels,tissue engineering,and regenerative medicine.
Jindřich Henry Kopeček was born in Strakonice,Czech Republic,as the son of Jan and Herta Zita (Krombholz) Kopeček. He is distinguished professor of pharmaceutical chemistry and distinguished professor of biomedical engineering at the University of Utah in Salt Lake City,Utah. Kopeček is also an honorary professor at Sichuan University in Chengdu,China. His research focuses on biorecognition of macromolecules,bioconjugate chemistry,drug delivery systems,self-assembled biomaterials,and drug-free macromolecular therapeutics.
Song Li is a Chancellor Professor and Department Chair of Bioengineering at University of California,Los Angeles. He received his Ph.D. in bioengineering from University of California,San Diego. Dr. Li was a Bioengineering faculty at University of California,Berkeley (2001-2015),and he moved to UCLA in 2016. His research is focused on cell engineering,mechanobiology,biomaterials,and regenerative medicine. He is well recognized bioengineer,and has been elected as a Fellow of the International Academy of Medical and Biological Engineering,Biomedical Engineering Society and American Institute for Medical and Biological Engineering.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Jennifer Hartt Elisseeff is an American biomedical engineer,ophthalmologist and academic. She is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical Engineering,Biomedical Engineering,Materials Science and Orthopedic Surgery. Elisseeff's research is in the fields of regenerative medicine and immunoengineering.
Steven R. Little is an American chemical engineer and pharmaceutical scientist. He currently holds the title of department chair,distinguished professor,and the William Kepler Whiteford Endowed Professor of Chemical Engineering at the University of Pittsburgh Swanson School of Engineering. He also holds secondary appointments in bioengineering,pharmaceutical sciences,immunology,ophthalmology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh.
The Pritzker School of Molecular Engineering (PME) is the first school of engineering at the University of Chicago. It was founded as the Institute for Molecular Engineering in 2011 by the university in partnership with Argonne National Laboratory. When the program was raised to the status of a school in 2019,it became the first school dedicated to molecular engineering in the United States. It is named for a major benefactor,the Pritzker Foundation.
Guillermo Antonio Ameer is the Daniel Hale Williams Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science and Surgery at the Feinberg School of Medicine of Northwestern University and is a fellow of the American Institute for Medical and Biological Engineering,Biomedical Engineering Society,American Institute of Chemical Engineers,American Association for the Advancement of Science,Materials Research Society,and American Academy of Arts and Sciences. He is an engineer,inventor,and entrepreneur.
Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech,which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.
Özlem Türeci is a German physician,scientist and entrepreneur. In 2008,she co-founded the biotechnology company BioNTech,which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021,she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse,Uğur Şahin,have won a number of awards.
Jennifer L. West is an American bioengineer. She is the current Dean of Engineering and Applied Science at the University of Virginia. She was the Fitzpatrick University Professor of Biomedical Engineering at Duke University from 2012-2021. In 2000,West cofounded Nanospectra Biosciences in Houston to develop a cancer therapy based on gold nanoparticles that destroy tumor cells and has been listed by MIT Technology Review as one of the 100 most innovative young scientists and engineers world wide.
Cassandra L. Fraser is an American synthetic chemist with an interest in biomedicine and sustainable design. She is a Full Professor of Chemistry at the University of Virginia.
Adekunle O. Odunsi is an American gynecologic oncologist. In 2020,Odunsi was named the director of the University of Chicago Comprehensive Cancer Center.
Jianjun Cheng is a Chinese material scientist.
Stuart L. Cooper is an American engineer. As a Full Professor and Chair of Ohio State University's Department of Chemical and Biomolecular Engineering,Cooper was elected to the National Academy of Engineering in 2011.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Nicole F. Steinmetz is a German–American biomedical engineer. She is a Full Professor in Biomaterials at the University of California,San Diego and Founding Director of the Center for Nano-ImmunoEngineering (nanoIE). Her research earned her Fellowship nominatioons from the American Institute for Medical and Biological Engineering,Biomedical Engineering Society,and National Academy of Inventors. Steinmetz uses various plant viruses to assist with drug delivery,molecular imaging,and vaccines.
Jeffrey Hubbell publications indexed by Google Scholar